ESR1 and neoplasm: Additionally, neoplasms with estrogen receptor 1 (ESR1)–NCOA2 fusions are more likely related to recurrences and the presence of infiltrative margins, and sometimes to the presence of an extensive rhabdoid component, as demonstrated by Bennett et al. [19].